These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37021137)

  • 41. Low Copeptin Levels in Patients With Intradialytic Hypotension.
    Korucu B; Helvaci O; Ozbas B; Yeter H; Yuce D; Elbeg S; Derici U
    Ther Apher Dial; 2019 Oct; 23(5):460-466. PubMed ID: 30549206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.
    Fenske W; Sandner B; Christ-Crain M
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):219-33. PubMed ID: 27156760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copeptin and arginine vasopressin at high altitude: relationship to plasma osmolality and perceived exertion.
    Mellor AJ; Boos CJ; Ball S; Burnett A; Pattman S; Redpath M; Woods DR
    Eur J Appl Physiol; 2015 Jan; 115(1):91-8. PubMed ID: 25213006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Copeptin in the differential diagnosis of hypotonic polyuria.
    Christ-Crain M; Fenske WK
    J Endocrinol Invest; 2020 Jan; 43(1):21-30. PubMed ID: 31368050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.
    Fenske W; Wanner C; Allolio B; Drechsler C; Blouin K; Lilienthal J; Krane V;
    J Am Soc Nephrol; 2011 Apr; 22(4):782-90. PubMed ID: 21415158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measuring copeptin, a surrogate for vasopressin in patients with hypertension - Can it identify those who are volume Responsive?
    Lobo R; Lieske JC; Donato LJ; Hickson LJ; Hodge DO; Chapman A; Schwartz GL; Jaffe AS
    Clin Biochem; 2023 Feb; 112():48-52. PubMed ID: 36470342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors.
    Eickhoff MK; Dekkers CCJ; Kramers BJ; Laverman GD; Frimodt-Møller M; Jørgensen NR; Faber J; Danser AHJ; Gansevoort RT; Rossing P; Persson F; Heerspink HJL
    J Clin Med; 2019 May; 8(6):. PubMed ID: 31159350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus.
    Villela-Torres ML; Higareda-Mendoza AE; Gómez-García A; Alvarez-Paredes AR; García-López E; Stenvikel P; Gu HF; Rashid-Qureshi A; Lindholm B; Alvarez-Aguilar C
    Arch Med Res; 2018 Jan; 49(1):36-43. PubMed ID: 29665969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
    Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
    Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial.
    Tanaka A; Shimabukuro M; Teragawa H; Okada Y; Takamura T; Taguchi I; Toyoda S; Tomiyama H; Ueda S; Higashi Y; Node K;
    Cardiovasc Diabetol; 2021 Jun; 20(1):105. PubMed ID: 34183012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.
    Timper K; Fenske W; Kühn F; Frech N; Arici B; Rutishauser J; Kopp P; Allolio B; Stettler C; Müller B; Katan M; Christ-Crain M
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2268-74. PubMed ID: 25768671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2006 Jan; 52(1):112-9. PubMed ID: 16269513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.
    Fenske WK; Christ-Crain M; Hörning A; Simet J; Szinnai G; Fassnacht M; Rutishauser J; Bichet DG; Störk S; Allolio B
    J Am Soc Nephrol; 2014 Oct; 25(10):2376-83. PubMed ID: 24722436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Copeptin as a novel biomarker of cardiometabolic syndrome.
    Szmygin H; Szydełko J; Matyjaszek-Matuszek B
    Endokrynol Pol; 2021; 72(5):566-571. PubMed ID: 34378786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
    Ohara K; Masuda T; Murakami T; Imai T; Yoshizawa H; Nakagawa S; Okada M; Miki A; Myoga A; Sugase T; Sekiguchi C; Miyazawa Y; Maeshima A; Akimoto T; Saito O; Muto S; Nagata D
    Nephrology (Carlton); 2019 Sep; 24(9):904-911. PubMed ID: 30578654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
    BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
    Puglisi S; Rossini A; Poli R; Dughera F; Pia A; Terzolo M; Reimondo G
    Front Endocrinol (Lausanne); 2021; 12():738848. PubMed ID: 34745006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Water and sodium homeostasis in conscious rabbits: role of arginine-vasopressin.
    Babini R; du Souich P
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):131-41. PubMed ID: 8321918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.
    Roussel R; El Boustany R; Bouby N; Potier L; Fumeron F; Mohammedi K; Balkau B; Tichet J; Bankir L; Marre M; Velho G
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2432-9. PubMed ID: 27049477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes.
    Davidson JA; Kuritzky L
    Postgrad Med; 2014 Oct; 126(6):33-48. PubMed ID: 25414933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.